A new study by researchers at Ireland's Maynooth University, based on patient data gathered by the US-based Michael J. Fox Foundation, found that an overwhelming 84% of patients with Parkinson's ...
Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage pharmaceutical company developing JOTROL, a patented resveratrol-based ...
Patients living with Parkinson’s disease are encouraged to engage in regular exercise to help manage symptoms and improve ...
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
The neurorehabilitation devices market is expected to grow from US$ 2.73 billion in 2023, with CAGR of 12.7% during 2023–2031 ...
In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was ...
GOTHENBURG, SE / ACCESS Newswire / January 23, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, January 23, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company dis ...
While celebrities like Michael J. Fox and Brett Favre have been open about their struggles with Parkinson's disease, it can present differently in everyone. Because of this, it's harder to identify ...
‘Chronos-PD’ is looking for biological signals that could indicate increased chance of developing Parkinson’s disease (PD) years before symptoms appear, leading to new diagnostic tools and ...
ANPD001 is a Personalized Dopamine Neuron Cell Replacement Therapy being Studied in Parkinson's Disease The Autologous-derived Study of a Parkinson's Investigational Regenerative therapy in an ...
Parkinson’s disease (PD) may lead to an increased risk of developing severe illness and a more complicated recovery from a COVID-19 infection. Generally, respiratory infections such as pneumonia can ...